Table 6.
Body weights and liver/kidney weights for rats treated for 45 days in the second stage (n = 10).
| Group | Body weight (g) | Relative liver weight (%) | Relative kidney weight (%) |
|---|---|---|---|
| C | 359.54 ± 6.39 | 2.56 ± 0.14 | 0.70 ± 0.06 |
| M | 359.95 ± 23.31 | 2.53 ± 0.15 | 0.82 ± 0.06▲▲ |
| A | 343.28 ± 31.62 | 2.60 ± 0.20 | 0.81 ± 0.06▲▲ |
| PF-1 | 355.77 ± 24.32 | 2.63 ± 0.19 | 0.85 ± 0.06▲▲ |
| PF-2 | 340.24 ± 27.60 | 2.57 ± 0.15 | 0.84 ± 0.07▲▲ |
| PF-3 | 341.50 ± 25.28 | 2.66 ± 0.20 | 0.80 ± 0.08▲▲ |
| PF-4 | 342.93 ± 21.75 | 2.54 ± 0.13 | 0.80 ± 0.03▲▲ |
C, control; M, model; A, allopurinol; PF-1, combination 1; PF-2, combination 2; PF-3, combination 3; PF-4, combination 4. ▲▲Significantly different from those of the control group at the level of P < 0.01.